All results

19 results for biomarkers als

• Magnetic resonance imaging and biomarkers for muscular dystrophy

  The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease…

  Ages

  5 Years - 62 Years

  Sexes

  Male

• TRACK-FA

  This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA).…

  Ages

  5 Years - N/A

  Sexes

  All

• REBIRTH

  The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of…

  Ages

  18 Years - N/A

  Sexes

  Female

• Comprehensive Outcomes for After Cancer Health (COACH)

  This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have…

  Ages

  18 Years - N/A

  Sexes

  All

• VITALISScE

  This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype called…

  Ages

  18 Years - N/A

  Sexes

  All

• Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…

  Ages

  18 Years - N/A

  Sexes

  All

• TAPUR: Testing FDA Approved Drugs That Target Specific Abnormal Tumor Genes in Pts w/Advanced Cancer

  The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a…

  Ages

  12 Years - N/A

  Sexes

  All

• Bio-BOOST

  BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with…

  Ages

  18 Years - N/A

  Sexes

  All

• NIH AIM 2 - Low Dose Pioglitazone in NASH

  To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic…

  Ages

  21 Years - 75 Years

  Sexes

  All

• Immunotherapy for Patients With Advanced Kidney Cancer, The PDIGREE Study

  This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…

  Ages

  18 Years - N/A

  Sexes

  All